Multicenter comparison of cyclacillin and amoxicillin in the treatment of acute streptococcal pharyngitis

Clin Ther. 1983;5(3):299-304.

Abstract

A double-blind study of 134 pediatric outpatients with acute streptococcal pharyngitis demonstrated that cyclacillin, administered three times a day for ten days, is as effective as a similar regimen of amoxicillin. Clinical success was achieved in 95% of the children treated with either drug. A bacteriological cure was seen in 82% of the children evaluated in the cyclacillin group and 90% of those evaluated in the amoxicillin group. The mean time required for remission of signs and symptoms in the respective treatment groups was 3.1 and 3.0 days. Only two patients (3%) in each treatment group experienced an adverse effect of the prescribed drug.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Amoxicillin / therapeutic use*
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Cyclacillin / therapeutic use*
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Humans
  • Infant
  • Male
  • Penicillins / therapeutic use*
  • Pharyngitis / drug therapy*
  • Streptococcal Infections / drug therapy*
  • United States

Substances

  • Penicillins
  • Cyclacillin
  • Amoxicillin